EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for INCPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 0.0588
December 31, 2025 0.0515
September 30, 2025 -0.0181
June 30, 2025 -0.0165
March 31, 2025 -0.0221
December 31, 2024 -0.0347
September 30, 2024 -0.0296
June 30, 2024 -0.037
March 31, 2024 -0.0607
December 31, 2023 -0.0505
September 30, 2023 -0.0468
June 30, 2023 -0.0708
March 31, 2023 -0.0654
December 31, 2022 -0.075
September 30, 2022 -0.0843
June 30, 2022 -0.0257
March 31, 2022 0.002
Date Value
December 31, 2021 0.0126
September 30, 2021 0.0261
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 -0.164
June 30, 2020 -0.2006
March 31, 2020 -0.2006
December 31, 2019 -0.2006
September 30, 2019 -0.0467
June 30, 2019 -0.0307
March 31, 2019 -0.0307
December 31, 2018 -0.0307
September 30, 2018 -0.0206
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Ascletis Pharma, Inc. -0.0517
CStone Pharmaceuticals Co. Ltd. -0.0442
RemeGen Co., Ltd. -0.1782
Adagene, Inc. -0.3743
Akeso, Inc. -0.1715